Godrej Agrovet Limited reported a strong conclusion to fiscal year 2026, with consolidated annual revenues surpassing the INR 10,000 crore milestone to reach INR 10,233 crore. The company achieved a 9% year-on-year revenue growth and a 17.2% increase in profit before tax. This performance was underpinned by broad-based volume growth, disciplined margin management, and a strategic focus on expanding its value-added and branded product portfolios across key business segments.
Financial Highlights of FY ’26
Godrej Agrovet delivered consistent performance throughout fiscal year 2026. For the Q4 period (January-March 2026), the company recorded consolidated revenues of INR 2,333 crore, representing a 9% year-on-year growth. Profit before tax (excluding exceptional items) for the quarter rose by 16.8% to INR 87 crore. On an annual basis, total revenue reached INR 10,233 crore, with profit before tax climbing 17.2% to INR 569 crore, reflecting improved operational efficiency and a stronger return on capital employed, which rose to 20%.
Segmental Performance Overview
The Animal Nutrition business saw strong momentum with a 15% volume growth in Q4, led by a 24% surge in cattle feed volumes. The Oil Palm segment concluded a landmark year characterized by record area expansion and high oil extraction ratios. Meanwhile, the Crop Care business is positioning for recovery following inventory challenges, with two new product launches—Ashitaka and TAKAI—expected to contribute significantly to future growth. In the foods category, the company is strategically shifting toward branded value-added products, including a move to decrease its Live Bird trading business in favor of new categories like frozen chicken and momos.
Strategic Outlook and Transformation
Management emphasized a long-term strategic shift toward becoming a more consumer-centric and market-facing organization. The company has augmented the board of Astec LifeSciences to leverage group expertise in chemicals and focus on CDMO-led growth. Looking ahead to FY ’27, the company targets early double-digit revenue growth at a consolidated level and mid-teen profit growth. Capital allocation remains disciplined, with approximately 50% of annual capital expenditure dedicated to the high-growth Oil Palm segment, aimed at realizing a long-term ‘demographic dividend’ from its plantation expansion.
Source: BSE
